1. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2012;22:229-237. PMID:
22463983.
2. Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N. Epigenetic findings in autism: new perspectives for therapy. Int J Environ Res Public Health 2013;10:4261-4273. PMID:
24030655.
3. Chung BH, Tao VQ, Tso WW. Copy number variation and autism: new insights and clinical implications. J Formos Med Assoc 2014;113:400-408. PMID:
24961180.
5. Srivastava AK, Schwartz CE. Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci Biobehav Rev 2014;46:161-174. PMID:
24709068.
6. Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry 2007;16:61-66. PMID:
16932856.
7. Liu X, Takumi T. Genomic and genetic aspects of autism spectrum disorder. Biochem Biophys Res Commun 2014;452:244-253. PMID:
25173933.
8. Smith CL, Bolton A, Nguyen G. Genomic and epigenomic instability, fragile sites, schizophrenia and autism. Curr Genomics 2010;11:447-469. PMID:
21358990.
9. Grabrucker AM. Environmental factors in autism. Front Psychiatry 2013;3:118PMID:
23346059.
10. Goldani AA, Downs SR, Widjaja F, Lawton B, Hendren RL. Biomarkers in autism. Front Psychiatry 2014;5:100PMID:
25161627.
11. Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, et al. Gene×Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front Psychiatry 2014;5:53PMID:
25136320.
12. Sener EF. Association of copy number variations in autism spectrum disorders: a systematic review. Chinese J Biol 2014;2014:1-9.
13. Schanen NC. Epigenetics of autism spectrum disorders. Hum Mol Genet 2006;15:R138-R150. PMID:
16987877.
14. Schreiber M, Dorschner M, Tsuang D. Next-generation sequencing in schizophrenia and other neuropsychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 2013;162B:671-678. PMID:
24132899.
15. Kato T. Whole genome/exome sequencing in mood and psychotic disorders. Psychiatry Clin Neurosci 2015;69:65-76. PMID:
25319632.
16. Han G, Sun J, Wang J, Bai Z, Song F, Lei H. Genomics in neurological disorders. Genomics Proteomics Bioinformatics 2014;12:156-163. PMID:
25108264.
17. Rosti RO, Sadek AA, Vaux KK, Gleeson JG. The genetic landscape of autism spectrum disorders. Dev Med Child Neurol 2014;56:12-18. PMID:
24116704.
18. Doherty JL, Owen MJ. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med 2014;6:29PMID:
24944580.
19. Toma C, Torrico B, Hervás A, Valdés-Mas R, Tristán-Noguero A, Padillo V, et al. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol Psychiatry 2014;19:784-790. PMID:
23999528.
20. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467. PMID:
271968.
21. Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A 1977;74:560-564. PMID:
265521.
22. van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends Genet 2014;30:418-426. PMID:
25108476.
23. França LT, Carrilho E, Kist TB. A review of DNA sequencing techniques. Q Rev Biophys 2002;35:169-200. PMID:
12197303.
24. Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet 2014;59:5-15. PMID:
24196381.
25. Yang Y, Xie B, Yan J. Application of next-generation sequencing technology in forensic science. Genomics Proteomics Bioinformatics 2014;12:190-197. PMID:
25462152.
26. International Human Genome Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004;431:931-945. PMID:
15496913.
27. Behjati S, Tarpey PS. What is next generation sequencing? Arch Dis Child Educ Pract Ed 2013;98:236-238. PMID:
23986538.
28. Day-Williams AG, Zeggini E. The effect of next-generation sequencing technology on complex trait research. Eur J Clin Invest 2011;41:561-567. PMID:
21155765.
29. Moorthie S, Mattocks CJ, Wright CF. Review of massively parallel DNA sequencing technologies. Hugo J 2011;5:1-12. PMID:
23205160.
30. Xuan J, Yu Y, Qing T, Guo L, Shi L. Next-generation sequencing in the clinic: promises and challenges. Cancer Lett 2013;340:284-295. PMID:
23174106.
31. Kayman Kürekçi G, Dinçer P. Next-generation DNA sequencing technologies. Erciyes Med J 2014;36:99-103.
32. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008;26:1135-1145. PMID:
18846087.
33. Pareek CS, Smoczynski R, Tretyn A. Sequencing technologies and genome sequencing. J Appl Genet 2011;52:413-435. PMID:
21698376.
34. Desai AN, Jere A. Next-generation sequencing: ready for the clinics? Clin Genet 2012;81:503-510. PMID:
22375550.
35. Zhang X. Exome sequencing greatly expedites the progressive research of Mendelian diseases. Front Med 2014;8:42-57. PMID:
24384736.
36. Ku CS, Wu M, Cooper DN, Naidoo N, Pawitan Y, Pang B, et al. Exome versus transcriptome sequencing in identifying coding region variants. Expert Rev Mol Diagn 2012;12:241-251. PMID:
22468815.
37. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-35. PMID:
19915526.
38. Biesecker LG. Exome sequencing makes medical genomics a reality. Nat Genet 2010;42:13-14. PMID:
20037612.
39. Wang JL, Yang X, Xia K, Hu ZM, Weng L, Jin X, et al. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain 2010;133:3510-3518. PMID:
21106500.
40. Hedges D, Burges D, Powell E, Almonte C, Huang J, Young S, et al. Exome sequencing of a multigenerational human pedigree. PLoS One 2009;4:e8232PMID:
20011588.
41. Kuhlenbäumer G, Hullmann J, Appenzeller S. Novel genomic techniques open new avenues in the analysis of monogenic disorders. Hum Mutat 2011;32:144-151. PMID:
21280146.
42. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010;42:790-793. PMID:
20711175.
43. Majewski J, Schwartzentruber J, Lalonde E, Montpetit A, Jabado N. What can exome sequencing do for you? J Med Genet 2011;48:580-589. PMID:
21730106.
44. Ku CS, Naidoo N, Pawitan Y. Revisiting Mendelian disorders through exome sequencing. Hum Genet 2011;129:351-370. PMID:
21331778.
45. Ezewudo M, Zwick ME. Evaluating rare variants in complex disorders using next-generation sequencing. Curr Psychiatry Rep 2013;15:349PMID:
23435969.
46. Jouan L, Gauthier J, Dion PA, Rouleau GA. Rare variants in complex traits: novel identification strategies and the role of de novo mutations. Hum Hered 2012;74:215-225. PMID:
23594499.
47. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014;515:209-215. PMID:
25363760.
48. Cukier HN, Dueker ND, Slifer SH, Lee JM, Whitehead PL, Lalanne E, et al. Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Mol Autism 2014;5:1PMID:
24410847.
49. Lee H, Lin MC, Kornblum HI, Papazian DM, Nelson SF. Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation. Hum Mol Genet 2014;23:3481-3489. PMID:
24501278.
50. Fukai R, Hiraki Y, Yofune H, Tsurusaki Y, Nakashima M, Saitsu H, et al. A case of autism spectrum disorder arising from a de novo missense mutation in POGZ. J Hum Genet 2015;60:277-279. PMID:
25694107.
51. Yuen RK, Thiruvahindrapuram B, Merico D, Walker S, Tammimies K, Hoang N, et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med 2015;21:185-191. PMID:
25621899.
52. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genet 2011;43:585-589. PMID:
21572417.
53. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole exome sequencing are strongly associated with autism. Nature 2012;485:237-241. PMID:
22495306.
54. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network Of de novo mutations. Nature 2012;485:246-250. PMID:
22495309.
55. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012;485:242-245. PMID:
22495311.
56. Bi C, Wu J, Jiang T, Liu Q, Cai W, Yu P, et al. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat 2012;33:1635-1638. PMID:
22865819.
57. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, Hill RS, et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 2012;8:e1002635PMID:
22511880.
58. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012;74:285-299. PMID:
22542183.
59. Marchani EE, Chapman NH, Cheung CY, Ankenman K, Stanaway IB, Coon HH, et al. Identification of rare variants from exome sequence in a large pedigree with autism. Hum Hered 2012;74:153-164. PMID:
23594493.
60. Nava C, Lamari F, Héron D, Mignot C, Rastetter A, Keren B, et al. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry 2012;2:e179PMID:
23092983.
61. Shi L, Zhang X, Golhar R, Otieno FG, He M, Hou C, et al. Whole-genome sequencing in an autism multiplex family. Mol Autism 2013;4:8PMID:
23597238.
62. Yu TW, Chahrour MH, Coulter ME, Jiralerspong S, Okamura-Ikeda K, Ataman B, et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron 2013;77:259-273. PMID:
23352163.
63. An JY, Cristino AS, Zhao Q, Edson J, Williams SM, Ravine D, et al. Towards a molecular characterization of autism spectrum disorders: an exome sequencing and systems approach. Transl Psychiatry 2014;4:e394PMID:
24893065.
64. Dong S, Walker MF, Carriero NJ, DiCola M, Willsey AJ, Ye AY, et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep 2014;9:16-23. PMID:
25284784.
65. Ionita-Laza I, Xu B, Makarov V, Buxbaum JD, Roos JL, Gogos JA, et al. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism. Proc Natl Acad Sci U S A 2014;111:343-348. PMID:
24344280.
66. Lee H, Lin MC, Kornblum HI, Papazian DM, Nelson SF. Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation. Hum Mol Genet 2014;23:3481-3489. PMID:
24501278.
67. Inoue E, Watanabe Y, Egawa J, Sugimoto A, Nunokawa A, Shibuya M, et al. Rare heterozygous truncating variations and risk of autism spectrum disorder: whole-exome sequencing of a multiplex family and follow-up study in a Japanese population. Psychiatry Clin Neurosci 2015;69:472-476. PMID:
25601189.
68. Butler MG, Rafi SK, Hossain W, Stephan DA, Manzardo AM. Whole exome sequencing in females with autism implicates novel and candidate genes. Int J Mol Sci 2015;16:1312-1335. PMID:
25574603.
69. Codina-Solà M, Rodríguez-Santiago B, Homs A, Santoyo J, Rigau M, Aznar-Laín G, et al. Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders. Mol Autism 2015;6:21PMID:
25969726.
70. Lozano R, Vino A, Lozano C, Fisher SE, Deriziotis P. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment. Eur J Hum Genet 2015;23:1702-1707. PMID:
25853299.
71. Egawa J, Watanabe Y, Wang C, Inoue E, Sugimoto A, Sugiyama T, et al. Novel rare missense variations and risk of autism spectrum disorder: whole-exome sequencing in two families with affected siblings and a two-stage follow-up study in a Japanese population. PLoS One 2015;10:e0119413PMID:
25806950.
72. Singleton AB. Exome sequencing: a transformative technology. Lancet Neurol 2011;10:942-946. PMID:
21939903.